Assembly Biosciences, Inc.
(NASDAQ : ASMB)

( )
ASMB PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -8.79%48.790.0%$394.90m
HZNPHorizon Therapeutics Plc 1.63%105.455.4%$200.53m
CTLTCatalent, Inc. -0.96%127.432.0%$140.61m
VRXValeant Pharmaceuticals International, Inc. -3.52%23.0014.1%$135.34m
ICLRICON plc 0.92%272.972.8%$114.99m
UTHRUnited Therapeutics Corp. -0.19%189.1413.9%$79.68m
JAZZJazz Pharmaceuticals Plc 1.08%121.162.1%$74.18m
BHCBausch Health Cos., Inc. -3.52%23.000.0%$67.62m
PRGOPerrigo Co. Plc -2.38%35.846.9%$57.32m
ARGXargenx SE 1.58%283.620.0%$53.93m
ENDPEndo International Plc -5.89%5.278.5%$48.50m
CPIXCumberland Pharmaceuticals, Inc. -18.49%4.100.6%$45.93m
QLGNQualigen Therapeutics, Inc. -0.68%1.460.0%$27.78m
IRWDIronwood Pharmaceuticals, Inc. -1.35%10.949.5%$25.41m
PCRXPacira Biosciences, Inc. 1.27%53.299.8%$24.31m

Company Profile

Assembly Biosciences, Inc. is a biotechnology company, which engages in the development of products for infectious diseases, such as chronic hepatitis B virus and illnesses associated with a dysbiotic microbiome. It focuses in two innovative platform programs: oral therapeutics for the treatment of hepatitis B virus, and the oral synthetic live biotherapeutics candidate. The company was founded by Uri Lopatin and Derek A. Small on October 7, 2005 and is headquartered in South San Francisco, CA.